Congenital hepatic fibrosis
Congenital Hepatic Fibrosis is a rare genetic disorder that primarily affects the liver. It is characterized by the abnormal development of the liver's biliary system, leading to fibrosis, or scarring, of the liver tissue. This condition is usually diagnosed in childhood or early adulthood and can lead to serious complications such as portal hypertension and kidney disease.
Symptoms[edit | edit source]
The symptoms of Congenital Hepatic Fibrosis can vary greatly from person to person. Some individuals may show no symptoms at all, while others may experience severe complications. Common symptoms include:
- Enlarged liver (hepatomegaly)
- Enlarged spleen (splenomegaly)
- Portal hypertension
- Varices
- Kidney disease
Causes[edit | edit source]
Congenital Hepatic Fibrosis is caused by mutations in the PKHD1 gene. This gene provides instructions for making a protein that is involved in the normal development of the kidneys and the liver. Mutations in this gene disrupt the normal development of these organs, leading to the characteristic features of this disorder.
Diagnosis[edit | edit source]
The diagnosis of Congenital Hepatic Fibrosis is usually made based on a combination of clinical findings and imaging studies. Liver biopsy may also be performed to confirm the diagnosis.
Treatment[edit | edit source]
There is currently no cure for Congenital Hepatic Fibrosis. Treatment is aimed at managing the symptoms and preventing complications. This may include medications to control portal hypertension, procedures to treat varices, and kidney transplantation in cases of severe kidney disease.
Prognosis[edit | edit source]
The prognosis for individuals with Congenital Hepatic Fibrosis varies depending on the severity of the condition and the presence of other health problems. With appropriate management, many individuals with this condition can live a normal lifespan.
See also[edit | edit source]
Congenital hepatic fibrosis Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD